Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 3,299 | 1,777 | 1,455 | 9,210 | 4,346 |
| Cost of Goods | 2,449 | 1,850 | 1,516 | 9,301 | 2,408 |
| Gross Profit | 850 | -73 | -61 | -91 | 1,938 |
| Operating Expenses | 18,448 | 19,185 | 18,539 | 99,886 | 12,817 |
| Operating Income | -17,149 | -18,408 | -18,084 | -99,676 | -10,471 |
| Other Income | 2,535 | 2,979 | 2,999 | 3,124 | 2,885 |
| Pre-tax Income | -14,614 | -15,429 | -15,085 | -96,552 | -7,586 |
| Net Income Continuous | -14,614 | -15,429 | -15,085 | -96,552 | -7,586 |
| Net Income | $-14,614 | $-15,429 | $-15,085 | $-96,552 | $-7,586 |
| EPS Basic Total Ops | -0.12 | -0.13 | -0.12 | -1.21 | -0.11 |
| EPS Basic Continuous Ops | -0.12 | -0.13 | -0.12 | -1.21 | -0.11 |
| EPS Diluted Total Ops | -0.12 | -0.13 | -0.12 | -1.21 | -0.11 |
| EPS Diluted Continuous Ops | -0.12 | -0.13 | -0.12 | -1.21 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.13 | -0.12 | -0.10 | -0.11 |
| EBITDA(a) | $-17,039 | $-18,294 | $-17,956 | $-99,533 | $-10,292 |